Biotech pharma

Tradewind BioScience

Website
Founded 2017Origin source ↗Checked 2026-09-15

Overview

Our lead candidate is a multifaceted attack antibody for ovarian cancer. Our approach enables targeting primary cancer cells directly, alongside enabling the immune system's natural anti-cancer function, all with one therapeutic antibody.

Company description As recorded 2026-11-08
About
Biotech pharmaBusinessesEnterpriseLicensing

Founders & team

Thaddeus Allen

Founder/CEO

As a full-time founder at Tradewind, my focus is on translating novel science into viable and novel therapeutic approaches and relating the value of our mission. This calls on skills and knowledge developed through 25 years of cancer research experience and more recent experience in business oriented rolls. Skills/Experience - PhD level cancer biologist - Management of a research team - Patent portfolio management and IP agreements - Scientific data analysis and interpretation

LinkedIn
Founder profile As recorded 2026-09-15
2team members reported
Source-reported As recorded 2026-09-15

Founded 2017 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The retained text does not establish product availability or customer use.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year
startup.observe Directory coverage · Sources & method